Vor Biopharma (VOR) Financial Statements

960 Followers

Vor Biopharma Financial Overview

Vor Biopharma's market cap is currently $674.58M. The company's EPS TTM is $82.041; its P/E ratio is 0.02; Vor Biopharma is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ -3.49M	$ -8.96M	$ 0.00
Operating Income	$ -371.64M	$ -121.19M	$ -126.04M	$ -93.42M	$ -69.02M
EBITDA	$ -368.75M	$ -117.66M	$ -114.37M	$ -83.13M	$ -67.58M
Net Income	$ -695.98M	$ -116.91M	$ -117.86M	$ -92.09M	$ -68.90M
Balance Sheet
Cash & Short-Term Investments	$ 455.21M	$ 91.93M	$ 137.18M	$ 230.25M	$ 207.47M
Total Assets	$ 464.13M	$ 142.89M	$ 209.83M	$ 299.37M	$ 242.59M
Total Debt	$ 3.00M	$ 31.83M	$ 35.66M	$ 38.91M	$ 18.01M
Net Debt	$ -393.49M	$ -50.12M	$ 4.30M	$ -18.79M	$ -101.79M
Total Liabilities	$ 628.44M	$ 46.23M	$ 59.10M	$ 48.76M	$ 26.33M
Stockholders' Equity	$ -164.31M	$ 96.66M	$ 150.72M	$ 250.61M	$ 216.26M
Cash Flow
Free Cash Flow	$ -143.65M	$ -99.89M	$ -101.36M	$ -93.61M	$ -73.04M
Operating Cash Flow	$ -142.71M	$ -99.66M	$ -100.29M	$ -85.14M	$ -69.14M
Investing Cash Flow	$ -48.80M	$ 96.86M	$ 71.01M	$ -94.09M	$ -91.65M
Financing Cash Flow	$ 503.81M	$ 53.39M	$ 2.94M	$ 117.14M	$ 232.91M

Currency in USD

Vor Biopharma Earnings and Revenue History

Income Statement >

Vor Biopharma Debt to Assets

Balance Sheet >

Vor Biopharma Cash Flow

Cash Flow >

Vor Biopharma Forecast EPS vs Actual EPS

Earnings >